Company
Serda
Fast and effective therapeutic debridement of burn injuries and chronic ulcers.
Also known as SERDA B.V, SERDA therapeutics
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- SERDA B.V
Claim, correct or request removal
Record updated 29 September 2026
About
The developmental prescription product of SERDA therapeutics is expected to bring fast and effective wound debridement, ease of use, high stability and low-moderate irritation potential, based on the preclinical data. It contains a proteolytic enzyme, which selectively digests and removes the necrotic tissue and eschar from the wound. This way the wound has the possibility to heal.
Funding snapshot
- Latest round
- Undisclosed2024-06-03
Funding rounds
- Round, 2024
- 2024-06-03
Products
- Other
- SN514
Loading relationship preview